UNI-EN 2:Notification of insiders' transactions
Firma: SOPHARMA ADSpis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Spis załączników:
| POLISH FINANCIAL SUPERVISION AUTHORITY | |||||||||||
|
| UNI - EN REPORT No | 2 | / | 2018 | |||||||
| Date of issue: | 2018-01-02 | ||||||||||
| Short name of the issuer | |||||||||||
| SOPHARMA AD | |||||||||||
| Subject | |||||||||||
| Notification of insiders' transactions | |||||||||||
| Official market - legal basis | |||||||||||
| art. 19. 3 MAR. | |||||||||||
| Unofficial market - legal basis | |||||||||||
| Contents of the report: | |||||||||||
| NOTIFICATION OF INSIDERS’ TRANSACTIONS SOPHARMA AD (the “Company”) announces that it was notified by Mr Ognian Donev, Chairman of the Board of Directors that he, executed the following transactions related to shares in the Company: Date of the transaction Operation Number of shares Unit price (BGN) 29.12.2017 Buy 1 354 4.2800 29.12.2017 Buy 705 4.2810 29.12.2017 Buy 1 568 4.2830 29.12.2017 Buy 873 4.2830 29.12.2017 Buy 500 4.2830 29.12.2017 Buy 427 4.2830 29.12.2017 Buy 473 4.2830 29.12.2017 Buy 1 073 4.2830 29.12.2017 Buy 27 4.2830 29.12.2017 Buy 500 4.2830 29.12.2017 Buy 81 4.2830 29.12.2017 Buy 269 4.2830 29.12.2017 Buy 1 619 4.2830 29.12.2017 Buy 31 4.2830 29.12.2017 Buy 181 4.2830 29.12.2017 Buy 1 319 4.2830 29.12.2017 Buy 400 4.2830 29.12.2017 Buy 81 4.2830 29.12.2017 Buy 1 519 4.2830 29.12.2017 Buy 719 4.2830 29.12.2017 Buy 281 4.2830 29.12.2017 Buy 672 4.2830 29.12.2017 Buy 328 4.2840 29.12.2017 Buy 200 4.2750 29.12.2017 Buy 300 4.2750 29.12.2017 Buy 500 4.2750 The transfer of the above-mentioned shares was executed on the Bulgarian Stock Exchange in Sofia (regulated market) by way of electronic trade. | |||||||||||
| Annexes | |||||||||||
| File | Description | ||||||||||
| Current report re insiders transactions -2-Donev.doc Current report re insiders transactions -2-Donev.doc | Notification of insiders' transactions | ||||||||||
| SOPHARMA AD | |||||||||||||
| (fullname of the issuer) | |||||||||||||
| SOPHARMA AD | Farmaceutyczny (far) | ||||||||||||
| (short name of the issuer) | (sector according to clasification of the WSE in Warsow) | ||||||||||||
| 1220 | Sofia | ||||||||||||
| (post code) | (city) | ||||||||||||
| IlienskoShosse | 16 | ||||||||||||
| (street) | (number) | ||||||||||||
| +359 2 813 42 00 | +359 2 936 02 86 | ||||||||||||
| (phone number) | (fax) | ||||||||||||
| (e-mail) | (web site) | ||||||||||||
| nd | |||||||||||||
| (NIP) | (REGON) | ||||||||||||
| SIGNATURE OF PERSONS REPRESENTING THE COMPANY | |||||
| Date | Name | Position / Function | Signature | ||
| 2018-01-02 | Ognian Donev | Executive director | |||
Cena akcji Sopharma
Cena akcji Sopharma w momencie publikacji komunikatu to 9.5 PLN. Sprawdź ile kosztuje akcja Sopharma aktualnie.
W tej sekcji znajdziesz wszystkie komunikaty ESPI EBI Sopharma.
